David R Hill
Affiliation: University College London
- Primaquine: report from CDC expert meeting on malaria chemoprophylaxis IDavid R Hill
National Travel Health Network and Centre, London School of Hygiene and Tropical Medicine Mortimer Market Centre, London, England
Am J Trop Med Hyg 75:402-15. 2006..The adult dose for primary prophylaxis is 30 mg daily begun 1 day before travel and continued for 7 days after return. This review will examine the evidence for these recommendations...
- Management of travellers' diarrhoeaDavid R Hill
National Travel Health Network and Centre, and London School of Hygiene and Tropical Medicine, Hospital for Tropical Diseases, London WC1E 6JB
BMJ 337:a1746. 2008
- Coming of age in travel medicine and tropical diseases: a need for continued advocacy and mentorshipDavid R Hill
National Travel Health Network and Centre, London School of Hygiene and Tropical Medicine, Mortimer Market Centre, London WC1E 6AU, UK
Infect Dis Clin North Am 19:xv-xxi. 2005
- Travelers' diarrheaDavid R Hill
National Travel Health Network and Centre and London School of Hygiene and Tropical Medicine, UCLH NHS Foundation Trust, London, UK
Curr Opin Infect Dis 23:481-7. 2010..Much of the evidence for the clinical description and management of travelers' diarrhea was generated years ago, however, there is new information on geographic and host risk, etiology, and prevention strategies...
- Oral cholera vaccines: use in clinical practiceDavid R Hill
National Travel Health Network and Centre, London, UK
Lancet Infect Dis 6:361-73. 2006..The vaccine can be expected to prevent 7% or less of cases of travellers' diarrhoea and should not be used for this purpose...
- The practice of travel medicine: guidelines by the Infectious Diseases Society of AmericaDavid R Hill
National Travel Health Network and Centre, London School of Hygiene and Tropical Medicine, London, WC1E 6AU, England
Clin Infect Dis 43:1499-539. 2006
- Evaluation of travel medicine practice by yellow fever vaccination centers in England, Wales, and Northern IrelandNicola L Boddington
National Travel Health Network and Centre, University College London Hospitals NHS Foundation Trust, London, England
J Travel Med 19:84-91. 2012..Prior to rolling out the program, NaTHNaC surveyed YFVCs in England...
- Quality improvement in travel medicine: a programme for yellow fever vaccination centres in England, Wales and Northern IrelandNicola L Boddington
University College, London, UK
Qual Prim Care 19:391-8. 2011..In 2005, NaTHNaC established a programme of registration, training, clinical standards and audit for YFVCs following the mandate of International Health Regulations (IHR, 2005)...
- Vaccine-preventable diseases and their prophylaxisJoanna S Herman
Hospital for Tropical Diseases, London, UK
Infect Dis Clin North Am 26:595-608. 2012..Considerations and advances in the vaccination of travelers are addressed...
- Prevention of malaria in long-term travelersAnna M Checkley
St George s Hospital, and London School of Hygiene and Tropical Medicine, SW17 0BZ, UK
Trends Parasitol 23:462-5. 2007..The essential elements of malaria prevention are discussed: awareness of risk, bite avoidance, chemoprophylaxis, rapid diagnosis, stand-by emergency treatment, and the importance of tailoring recommendations to the individual...
- Teaching global public health in the undergraduate liberal arts: a survey of 50 collegesDavid R Hill
National Travel Health Network and Centre, London, United Kingdom
Am J Trop Med Hyg 87:11-5. 2012..From the standpoint of basic human rights, suffering and inequity cannot be tolerated. Williams College student during a global health short course...
- Analysis of yellow fever vaccination practice in EnglandNaomi Bryant
National Travel Health Network and Centre, London, UK
J Travel Med 15:287-93. 2008....
- The burden of illness in international travelersDavid R Hill
National Travel Health Network and Center, London
N Engl J Med 354:115-7. 2006
- Preventing malaria in travellersDavid G Lalloo
Liverpool School of Tropical Medicine, Liverpool L3 5QA
BMJ 336:1362-6. 2008
- Travel vaccines: current practice and future aspectsDavid R Hill
Expert Rev Vaccines 7:527-30. 2008
- The revised International Health Regulations (2005): impact on yellow fever vaccination in clinical practiceAnnelies Wilder-Smith
Am J Trop Med Hyg 78:359-60. 2008
- Safety of Typhim Vi vaccine in a postmarketing observational studyLeonard C Marcus
Travelers Health and Immunization Services, Newton, MA, USA
J Travel Med 14:386-91. 2007..We present the results of the largest safety study of this Vi vaccine to date...
- UK malaria treatment guidelinesDavid G Lalloo
Clinical Research Group, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool L3 5QA, UK
J Infect 54:111-21. 2007..An acute attack of malaria does not confer protection from future attacks: individuals who have had malaria should take effective anti-mosquito precautions and chemoprophylaxis during future visits to endemic areas...
- Largest ever Marburg haemorrhagic fever outbreak, AngolaJo Lawrence
Health Protection Agency Centre for Infections, London, United Kingdom
Euro Surveill 10:E050407.2. 2005
- Improving the evidence base for pre-travel advice: the importance of surveillance of travel-associated infectionJoanne Lawrence
Br J Gen Pract 55:566-8. 2005
- Giardia intestinalisSyed A Ali
Division of Infectious Diseases, University of Connecticut School of Medicine, Farmington, Connecticut, USA
Curr Opin Infect Dis 16:453-60. 2003..Continued study of the role of Giardia in chronic diarrhea and malnutrition in developing regions will help focus strategies to improve childhood growth and nutrition...
- Acute oral dexamethasone administration reduces levels of orphan GPCR glucocorticoid-induced receptor (GIR) mRNA in rodent brain: potential role in HPA-axis functionFiona Adams
Organon Laboratories Ltd ML1 5SH, Newhouse, UK
Brain Res Mol Brain Res 117:39-46. 2003..05), compared with vehicle. These data demonstrate the in vivo regulation of GIR in response to glucocorticoids and suggest a potential role for GIR in mediating the response to altered levels of glucocorticoids in disease states...